X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Torrent Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ACTAVIS (US) - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ACTAVIS
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
ACTAVIS
Dec-14
TORRENT PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,55018,654-   
Low Rs1,14411,378-   
Sales per share (Unadj.) Rs354.73,359.1-  
Earnings per share (Unadj.) Rs40.1-419.2-  
Cash flow per share (Unadj.) Rs64.2308.2-  
Dividends per share (Unadj.) Rs14.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs273.17,285.7-  
Shares outstanding (eoy) m169.22265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.84.5 84.9%   
Avg P/E ratio x33.6-35.8 -93.8%  
P/CF ratio (eoy) x21.048.7 43.0%  
Price / Book Value ratio x4.92.1 239.2%  
Dividend payout %34.90-   
Avg Mkt Cap Rs m227,8973,992,820 5.7%   
No. of employees `00014.721.6 68.1%   
Total wages/salary Rs m11,3530-   
Avg. sales/employee Rs Th4,083.041,350.9 9.9%   
Avg. wages/employee Rs Th772.30-   
Avg. net profit/employee Rs Th461.3-5,160.2 -8.9%   
INCOME DATA
Net Sales Rs m60,021893,180 6.7%  
Other income Rs m2,988-2,229 -134.1%   
Total revenues Rs m63,009890,950 7.1%   
Gross profit Rs m13,493114,742 11.8%  
Depreciation Rs m4,086193,406 2.1%   
Interest Rs m3,08528,173 10.9%   
Profit before tax Rs m9,310-109,066 -8.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,000 0.0%   
Tax Rs m2,529-5,607 -45.1%   
Profit after tax Rs m6,781-111,459 -6.1%  
Gross profit margin %22.512.8 175.0%  
Effective tax rate %27.25.1 528.3%   
Net profit margin %11.3-12.5 -90.5%  
BALANCE SHEET DATA
Current assets Rs m52,623470,591 11.2%   
Current liabilities Rs m52,022343,199 15.2%   
Net working cap to sales %1.014.3 7.0%  
Current ratio x1.01.4 73.8%  
Inventory Days Days12058 206.1%  
Debtors Days Days7666 115.0%  
Net fixed assets Rs m85,016109,066 77.9%   
Share capital Rs m8460-   
"Free" reserves Rs m45,3760-   
Net worth Rs m46,2221,937,274 2.4%   
Long term debt Rs m41,1151,015,169 4.1%   
Total assets Rs m142,4323,550,385 4.0%  
Interest coverage x4.0-2.9 -139.9%   
Debt to equity ratio x0.90.5 169.7%  
Sales to assets ratio x0.40.3 167.5%   
Return on assets %6.9-2.3 -295.3%  
Return on equity %14.7-5.8 -255.0%  
Return on capital %14.2-3.0 -471.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,9800-   
CASH FLOW
From Operations Rs m8,942153,376 5.8%  
From Investments Rs m-47,070-367,242 12.8%  
From Financial Activity Rs m34,174206,337 16.6%  
Net Cashflow Rs m-3,655-7,529 48.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.38 Rs / USD

Compare TORRENT PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: AJANTA PHARMA  STERLING BIOTECH  ORCHID PHARMA LTD  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Indian Indices Continue Rally, Oil Prices, and Top Stocks in Action Today(Pre-Open)

On Tuesday, share markets in India traded on a positive note most of the day and ended higher. The BSE Sensex closed higher by 268 points to end the day at 38,363.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Mar 19, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - PIRAMAL ENTERPRISES COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS